Shapely operates a telehealth platform delivering physician-led weight loss care directly to patients at home. Founded by Dr. Justin Zaghi, the company is structured as Zaghi Medical Inc., a California Professional Corporation, and serves patients across California, Texas, Florida, and New York.
The platform combines remote medication management - including GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound - with monthly video visits from weight loss experts and personalized dietitian consultations. Patients receive unlimited support through an integrated chat system and companion mobile application. The company accepts Medicare and major PPO insurance plans, positioning its evidence-based approach as an alternative to traditional weight loss programs.
Shapely's clinical model emphasizes medication management, nutritional guidance, and ongoing medical oversight. The service is structured around monthly touchpoints with specialists, supported by continuous digital engagement through chat and app-based tools. This combination of scheduled clinical visits and asynchronous support channels forms the core of the company's delivery model for remote obesity treatment.